Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityNo recent work listed

Pengping Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-5984-8297; OpenAlex author ID A5012652787. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: 2 papers · 2020: 1 paper

Papers 7

  1. FHL3 promotes pancreatic cancer invasion and metastasis through preventing the ubiquitination degradation of EMT associated transcription factors. Co-author DOI 10.18632/aging.102564↗
  2. Oncogenic Activities Of UBE2S Mediated By VHL/HIF-1α/STAT3 Signal Via The Ubiquitin-Proteasome System In PDAC. Co-author DOI 10.2147/ott.s228522↗
  3. Pancreatic cancer-derived exosomes promoted pancreatic stellate cells recruitment by pancreatic cancer. Co-author DOI 10.7150/jca.27590↗
  4. Thymidylate synthase prompts metastatic progression through the dTMP associated EMT process in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2018.01.026↗
  5. Pancreatic cancer-derived exosomes suppress the production of GIP and GLP-1 from STC-1 cells in vitro by down-regulating the PCSK1/3. Co-author DOI 10.1016/j.canlet.2018.05.027↗
  6. Protein salvador homolog 1 acts as a tumor suppressor and is modulated by hypermethylation in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.17972↗
  7. Expression profile and prognostic value of SAV1 in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s13277-016-5457-4↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yizhao Zhou · 4 shared papers, 2018–2020 · strength 0.33
  2. Yulian Wu · 4 shared papers, 2018–2020 · strength 0.33
  3. Muxing Kang · 3 shared papers, 2018–2019 · strength 0.23
  4. Yuefeng Zhang · 2 shared papers, 2018–2020 · strength 0.18
  5. Lantian Wang · 2 shared papers, 2018 · strength 0.14
  6. Yiyi Liang · 1 shared paper, 2019 · strength 0.11
  7. Wei Hu · 1 shared paper, 2019 · strength 0.11
  8. Lei Wang · 1 shared paper, 2019 · strength 0.11
  9. Maoming Xiong · 1 shared paper, 2020 · strength 0.10
  10. Yi Zhu · 1 shared paper, 2020 · strength 0.10
  11. Yue‐Feng Zhang · 1 shared paper, 2019 · strength 0.09
  12. Xiaoman He · 1 shared paper, 2019 · strength 0.09
  13. Bin Juan Yang · 1 shared paper, 2018 · strength 0.07
  14. Lei Wang · 1 shared paper, 2017 · strength 0.07
  15. Xiaodong Jiang · 1 shared paper, 2017 · strength 0.07
  16. Wenjie Lu · 1 shared paper, 2018 · strength 0.07
  17. Qing Chen · 1 shared paper, 2018 · strength 0.07
  18. Qingqu Guo · 1 shared paper, 2018 · strength 0.07
  19. Lei Wang · 1 shared paper, 2016 · strength 0.06
  20. Liwei Wang · 1 shared paper, 2016 · strength 0.06
  21. Jiujie Cui · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.